Abstract

A small number of peripheral-blood CD34+ cells, when grown ex vivo, can supply a population of hematopoietic precursors that have the ability to restore blood formation in patients treated with high doses of chemotherapy. This method, which requires only a small volume of the patient's blood, may reduce the risk of tumor-cell contamination, circumvent the need for leukapheresis, and allow repeated cycles of high-dose chemotherapy.

Keywords

MedicineEx vivoHaematopoiesisProgenitor cellChemotherapyIn vivoProgenitorCancer researchStem cellInternal medicineBiologyCell biology

Related Publications

Publication Info

Year
1995
Type
article
Volume
333
Issue
5
Pages
283-287
Citations
370
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

370
OpenAlex

Cite This

Wolfram Brugger, Shelly Heimfeld, Ronald Berenson et al. (1995). Reconstitution of Hematopoiesis after High-Dose Chemotherapy by Autologous Progenitor Cells Generated ex Vivo. New England Journal of Medicine , 333 (5) , 283-287. https://doi.org/10.1056/nejm199508033330503

Identifiers

DOI
10.1056/nejm199508033330503